A study of blood samples collected up to nine years before a cancer diagnosis found changes in the DNA that captured the body ...

Veracyte has acquired Convergent Genomics in a transaction valued at up to $180 million, adding the UroAmp urinary tumor DNA ...

Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) that offers CLIA-certified ...

A multidisciplinary panel created a competency model to address the expanding demands of genomic technologies on the cancer care workforce.

Researchers found that genome-wide plasma cfDNA methylation profiles collected before diagnosis contained early molecular ...

A rapid autopsy programme provides valuable resources to enable detailed molecular and genetic analyses of the temporal evolution of aggressive histological subtypes and therapy resistance in ...

In the same vein as weather forecast models that predict developing storms, researchers have now developed a method to predict the cell activity in tissues over time. The new software combines ...

Hiroshima University researchers have developed a practical framework to identify candidate pathogenic variants hidden among the large number of variants of uncertain significance (VUS) detected in ...

Insights derived from one of the largest datasets with over 250 million harmonized variant calls from over 8,000 tumor-normal whole genomes from more than 30 different cancer types will be presented ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The Cancer Genomics and Epigenomics (CGE) Program is the hub for cancer genome and epigenome discoveries and technology developments at Case CCC. The overarching goals of CGE are to discover the ...